Authors



Oliver Mills, PharmD

Latest:

NAPLEX Preparation: Tips for the Most Important Exam of Your Career

Before you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.


Karen Tirozzi, Vice President of Solutions, ZappRx

Latest:

A Look Back and at What Lies Ahead for Specialty Pharmacy in 2019

There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.



Suellen M. Curkendall, PhD

Latest:

Out-of-Pocket Healthcare Expenditures and Caps in Patients With Chronic Conditions

A small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.


Daniel Roth, PharmD Candidate

Latest:

Natural Products on Deck: Keeping Joints in the Game

Many patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.


Bianca Lezcano, 2014 PharmD candidate

Latest:

Passing the First Test: How to Impress on the Residency Interview

With more and more students applying for residency positions, off-site interviews are becoming an important first step in the selection process.


Albert Bach, PharmD

Latest:

Improving Adherence With Immunization Schedules

As a whole, adult vaccination coverage has remained unchanged without significant improvement.




Richard W. Grant, MD, MPH

Latest:

Impact of Antidepressant Therapy on Statin Adherence and Cholesterol Control

Among patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.


Jessica Capparelli, PharmD Candidate

Latest:

OTC, Prescription Drug Abuse Increasing Among Adolescents

Neighborhood pharmacists can provide support and information.


Aimee Simone, Pharmacy Times

Latest:

Christiana Care Implements Formulary Decision Process Focused on Value

The new process takes into account the efficacy, risk, cost, and societal benefit of a given specialty drug in determining whether it should be added to the hospital's formulary.




Jennifer L. Cruz, PharmD, BCPS

Latest:

Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 Diabetes

Diabetes is a complex disease affecting 29.1 million individuals in the United States.




Pranish Kantesaria, PharmD

Latest:

Personal Medical Liaison to Help Transition Between Hospital and Home

A new healthcare role will help bridge the gap between hospital, primary care, and home for patients.


Robert Bailey, MD

Latest:

Low Reporting of Medicaid Diabetes Quality Measures: Room for Improvement?

In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.


Chanhee Jo, PhD

Latest:

Evaluation of Dual Versus Triple Therapy for Hepatitis C

In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.


Eamonn Murphy, PharmD, BCPS

Latest:

A Collaborative Approach to Specialty Pharmacy at an Academic Medical Center

The SUNY Outpatient Pharmacy has developed a strong collaboration with specialty pharmacy personnel and clinically embedded pharmacists.


Jun Wu, PhD

Latest:

Hormone Therapy Adherence and Costs in Women With Breast Cancer

Suboptimal adherence to hormone therapy was associated with higher medical costs, but optimal adherence was not associated with total cost savings across a 4-year period.


Joe Cotton, 2018 PharmD Candidate

Latest:

Breaking Through Breakthrough Cancer Pain

Breakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled


Andrea R. Gauld, PharmD, BCACP, BCPS

Latest:

The Role of the Community Pharmacist in Managing Long-Acting Reversible Contraception

This Continuing Education activity is supported by an educational grant from Teva Pharmaceuticals and Merck Sharp & Dohme Corp.


Adam Hochron, Associate Editor, HCPLive.com

Latest:

"Superbug" Exposure Reported at UCLA Hospital

More than 100 patients at a hospital in Los Angeles may have been exposed to a "superbug" that has been linked to at least 2 deaths at the facility.


Christa Eans, PharmD, AAHIVP, MSPBA

Latest:

ERLEADA for Prostate Cancer

On February 14, 2018, the FDA approved apalutamide (Erleada) by Janssen Biotech Inc for the treatment of nonmetastatic castration-resistant prostate cancer (NM-CRPC).


Jackie Syrop

Latest:

Companies Target Personalized Medicine in Planned Acquisitions

A majority of life sciences companies are planning on acquisitions and are targeting companies with a personalized medicine focus.



Adam Grana

Latest:

LinkedIn to Pharmacy: A Student Pharmacist's Guide

Developing industry connections is crucial for aspiring pharmacists.